- Home
- BBNX vs ATAI Comparison
BBNX vs ATAI Comparison
Compare BBNX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBNX | ATAI |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BBNX | ATAI |
|---|---|---|
| Price | $29.73 | $4.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $28.09 | $14.00 |
| AVG Volume (30 Days) | 672.2K | ★ 3.6M |
| Earning Date | 10-28-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,570,000.00 | $3,018,000.00 |
| Revenue This Year | $52.13 | $943.83 |
| Revenue Next Year | $36.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 67.01 | ★ 811.78 |
| 52 Week Low | $8.89 | $1.15 |
| 52 Week High | $32.71 | $6.75 |
Technical Indicators
Market Signals| Indicator | BBNX | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 44.63 |
| Support Level | $28.00 | $4.25 |
| Resistance Level | $30.50 | $4.63 |
| Average True Range (ATR) | 1.82 | 0.22 |
| MACD | -0.26 | 0.08 |
| Stochastic Oscillator | 38.33 | 52.91 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.